Inventor · disambiguated record
Soon Jae Park
Also filed as: PARK SOON · PARK SOON J · PARK SOON JAE
20 granted patents·10 pending applications·73 citations·filing 1994–2025
93Inventor score
Files withALTEOGEN INC21SAMSUNG ELECTRONICS CO LTD4LG CHEMICAL LTD2CJ HEALTHCARE CORP1LUCKY LIMITED CO1
Top patents by PatentIndex Score
30 records- 0194US9982032B2Stable liquid formulation of fusion protein with IgG Fc domainALTEOGEN INC·Filed 2016·Granted May 29, 2018·19 cites·4 claims
- 0287US9474803B2Composition for stabilizing fusion protein in which protein and FC domain are fusedALTEOGEN INC·Filed 2013·Granted Oct 25, 2016·5 cites·7 claims
- 0385US9814782B2Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for sameALTEOGEN INC·Filed 2013·Granted Nov 14, 2017·10 cites·16 claims
- 0483US7860296B2Method and system for testing a display panel assemblySAMSUNG ELECTRONICS CO LTD·Filed 2005·Granted Dec 28, 2010·7 cites·24 claims
- 0581US11080386B2Method for providing smart key service and electronic device thereofSAMSUNG ELECTRONICS CO LTD·Filed 2018·Granted Aug 3, 2021·3 cites·9 claims
- 0677US12371683B2Hyaluronidase variants and pharmaceutical composition comprising the sameALTEOGEN INC·Filed 2019·Granted Jul 29, 2025·1 cites·49 claims
- 0775US11235065B2Antibody-drug conjugate comprising modified antibodyALTEOGEN INC·Filed 2017·Granted Feb 1, 2022·2 cites·12 claims
- 0875US2025129352A1Method for producing recombinant hyaluronidaseALTEOGEN INC·Filed 2024·Application pending·0 cites
- 0975US2025136964A1Method for producing recombinant hyaluronidaseALTEOGEN INC·Filed 2024·Application pending·0 cites
- 1072US11414476B2Method for producing fusion protein having IgG Fc domainALTEOGEN INC·Filed 2016·Granted Aug 16, 2022·1 cites·14 claims
- 1172US10686338B2Electronic device and foreign object detection method for electronic deviceSAMSUNG ELECTRONICS CO LTD·Filed 2017·Granted Jun 16, 2020·2 cites·13 claims
- 1268US2025368976A1Novel hyaluronidase variants and pharmaceutical composition containing the sameALTEOGEN INC·Filed 2025·Application pending·0 cites
- 1365US12090210B2Antibody-drug conjugate comprising modified antibodyALTEOGEN INC·Filed 2021·Granted Sep 17, 2024·0 cites·11 claims
- 1465US9051395B2Alpha-1 antitrypsin variant, preparation method thereof and use thereofPARK SOON JAE·Filed 2012·Granted Jun 9, 2015·2 cites·7 claims
- 1564US12221638B2Method for producing recombinant hyaluronidaseALTEOGEN INC·Filed 2021·Granted Feb 11, 2025·0 cites·15 claims
- 1662US2022348636A1Method for producing fusion protein having igg fc domainALTEOGEN INC·Filed 2022·Application pending·0 cites
- 1762US2022289864A1Pharmaceutical composition for subcutaneous injection comprising human hyaluronidase ph20 variant and drugALTEOGEN INC·Filed 2022·Application pending·0 cites
- 1859US2025122492A1N-terminal and/or C-terminal Cleaved Soluble PH20 Polypeptide and Use ThereofALTEOGEN INC·Filed 2023·Application pending·0 cites
- 1956US11866492B2Antibody specifically binding to FOLR1 and uses thereofALTEOGEN INC·Filed 2019·Granted Jan 9, 2024·0 cites·10 claims
- 2055US12248057B2Method for providing service related to electronic device by forming zone, and device thereforSAMSUNG ELECTRONICS CO LTD·Filed 2021·Granted Mar 11, 2025·0 cites·20 claims
- 2155US2025243240A1Method for purifying fusion protein having igg fc domainALTEOGEN INC·Filed 2022·Application pending·0 cites
- 2252US2023250408A1Novel hyaluronidase variants with improved stability and pharmaceutical composition comprising the sameALTEOGEN INC·Filed 2021·Application pending·0 cites
- 2352US2025009850A1Pharmaceutical composition comprising human hyaluronidase ph20 and drugALTEOGEN INC·Filed 2022·Application pending·0 cites
- 2451US6428997B1Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteinsLG CHEMICAL LTD·Filed 1998·Granted Aug 6, 2002·9 cites·11 claims
- 2549US9821059B2Composition for stabilizing protein and pharmaceutical formulation comprising the sameALTEOGEN INC·Filed 2015·Granted Nov 21, 2017·0 cites·6 claims
- 2648US2017119903A1Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for sameALTEOGEN INC·Filed 2016·Application pending·0 cites
- 2745US6362320B1Process for purifying hepatitis B viral surface antigen comprising pres2 peptideLG CHEMICAL LTD·Filed 1999·Granted Mar 26, 2002·8 cites·13 claims
- 2841US11981719B2Growth hormone receptor antagonists and fusion proteins thereofALTEOGEN INC·Filed 2018·Granted May 14, 2024·0 cites·15 claims
- 2940US9902753B2Method of purifying a long-acting human growth hormoneCJ HEALTHCARE CORP·Filed 2013·Granted Feb 27, 2018·0 cites·10 claims
- 3029US5569598AExtracellular aminopeptidase isolated from Streptococcus thermonitrificans cultureLUCKY LIMITED CO·Filed 1994·Granted Oct 29, 1996·4 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Soon Jae Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →